About the Artist

Ann dabbled in the arts as a teen and young adult and began to paint seriously in 1989 after spending a year at L’Abri in the south of England where she became inspired to paint.  

Ann states, “My art is an important form of communication for me.  It can express who I am and how I see the world in all it’s beauty and fallen-ness.  I am thankful to God for the ability to paint,  and I feel both humbled and blessed that I have the opportunity to use it, hopefully, in a way that pleases Him.  Primarily a figurative artist using oils in a more traditional realist style, I have also explored other styles and themes including landscape and still life, specifically reflective pieces.

Within the art world, originality is valued.  I prefer to cause one to stop and reflect on the ordinary in life, to find beauty in it, to simply enjoy it or be comfort by it, to sometimes ponder deeper thoughts or allow it to be a place to find momentary rest or distraction from the brokenness or business of one’s life.”   

Although Ann no longer enter art competition, in the past her works have won many awards, including Best of Show, People’s Choice Awards and a merit award in international juried competition.  Her work can be found in homes across the United States as well as several other countries around the world.


In January of 2007 Ann was diagnosed with eye cancer.  Choroidal melanoma, although the most common primary eye cancer, is rare (about 6 of one million) found behind the retina of the eye.    This is not a diagnosis anyone wants to hear but especially a visual artist, and her initial fear was that it would affect her ability to paint.  She painted frantically for nine months after diagnosis, then laid her painting aside as she went through radiation and a couple surgeries on the eye.  In August of 2008 she returned to her painting and felt like she had ‘come home again’.   Although this cancer will take the lives of approximately 50% of those diagnosed with it and can metastasize 5, 15, 25 years after initial treatment, she is at low risk for mestastasis and thankfully still in remission as of 2020.  For more information on Ocular Melanoma, click here to visit the Ocular Melanoma Foundation